A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study.
type: Dataset
description: International audience
issued: 2026-05-11T04:51:44.021556
language: en
modified: 2026-05-11T04:51:44.021561
contact point: Organization
  fn: CCSD
keyword: infoeu-reposemanticsarticle
keyword: journal-articles
keyword: mesh-adult
keyword: mesh-aged
keyword: mesh-aged-80-and-over
keyword: mesh-antineoplastic-combined-chemotherapy-protocols
keyword: mesh-cyclophosphamide
keyword: mesh-dexamethasone
keyword: mesh-doxorubicin
keyword: mesh-female
keyword: mesh-humans
keyword: mesh-liposomes
keyword: mesh-male
keyword: mesh-middle-aged
keyword: mesh-neoplasm-recurrence-local
keyword: mesh-polyethylene-glycols
keyword: mesh-precursor-cell-lymphoblastic-leukemia-lymphoma
keyword: mesh-survival-rate
keyword: mesh-treatment-outcome
keyword: mesh-vincristine
keyword: sdvcanlife-sciences-q-biocancer
landing page: 0390-6078

A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study.
type: Distribution
format: HTML
issued: 2026-05-11T04:51:44.043525
modified: 2026-05-11T04:51:44.001501
access URL: https://hal.science/hal-00821138

test_moissonnage_selune
type: Agent